Stanford study could pave way to new treatment for rare jaw tumor
Researchers have identified the mutations underlying a rare, understudied type of jaw tumor called ameloblastoma, and have also found FDA-approved drugs that may help treat the tumors.
Click here to read the full press release.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.